The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Berger Mark Stanley since year 2005.
The trader's CIK number is 1700283.
At the time of this reporting, Berger Mark Stanley is the Chief Medical Officer of Actinium Pharmaceuticals, Inc. .
(stock ticker symbol ATNM).
See this page for all insider trading activities at Actinium Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-15||ATNM||Actinium Pharmaceuticals, Inc.||Buy||5,000||1.11||5,550|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berger Mark Stanley (Chief Medical Officer of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.